跳至主要内容
临床试验/NCT01016782
NCT01016782已完成3 期

Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study of 0444 Gel

Fougera Pharmaceuticals Inc.0 个研究点目标入组 867 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
867
主要终点
Reduction in the number of papules and pustules from Baseline to End of Treatment

研究概览

简要总结

The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the Treatment of Inflammatory Lesions of Rosacea.

Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of rosacea
  • Good health with the exception of rosacea
  • Papsules and pustules minimum and maximum requirements

排除标准

  • Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period.
  • Subjects who have any systemic or dermatological disorders with the exception of rosacea

研究组 & 干预措施

Test

Experimental

Test product that contains active pharmaceutical ingredient

干预措施: 0444 (Drug)

Reference

Active Comparator

Reference product that contains active pharmaceutical ingredient

干预措施: 0444 (Drug)

Vehicle

Placebo Comparator

Placebo that contains no active pharmaceutical ingredient

干预措施: 0444 (Drug)

结局指标

主要结局

Reduction in the number of papules and pustules from Baseline to End of Treatment

时间窗: 70 Days

次要结局

  • Reduction in the Investigator's Global Evaluation, Clear or Almost Clear(70 Days)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Study of 0444 Gel in the Treatment of Inflammatory... | 临床试验